Neural Analytics has received 510(k) clearance from the FDA for its next-generation ultrasound device, the Lucid M1 Transcranial Doppler Ultrasound System.

The device system is a battery-operated medical-grade tablet device designed to be moved easily throughout a medical facility in a range of settings that require the rapid assessment of blood flow in the brain to expedite treatment for conditions such as traumatic brain injury.

There are 2.5 million people affected by TBI each year in the U.S. and 14.8 million people affected globally. — Cynthia Jessup